JP2003127542A5 - - Google Patents

Download PDF

Info

Publication number
JP2003127542A5
JP2003127542A5 JP2001322562A JP2001322562A JP2003127542A5 JP 2003127542 A5 JP2003127542 A5 JP 2003127542A5 JP 2001322562 A JP2001322562 A JP 2001322562A JP 2001322562 A JP2001322562 A JP 2001322562A JP 2003127542 A5 JP2003127542 A5 JP 2003127542A5
Authority
JP
Japan
Prior art keywords
group
recording medium
optical recording
aralkyl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001322562A
Other languages
Japanese (ja)
Other versions
JP4178783B2 (en
JP2003127542A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2001322562A priority Critical patent/JP4178783B2/en
Priority claimed from JP2001322562A external-priority patent/JP4178783B2/en
Publication of JP2003127542A publication Critical patent/JP2003127542A/en
Publication of JP2003127542A5 publication Critical patent/JP2003127542A5/ja
Application granted granted Critical
Publication of JP4178783B2 publication Critical patent/JP4178783B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Claims (3)

基板上に、レーザーによる情報の記録及び/又は再生が可能な記録層が設けられた光学記録媒体であって、該記録層に、下記一般式[I]で示されるカルボスチリル化合物または1,8−ナフチリジン化合物を含有することを特徴とする光学記録媒体。
Figure 2003127542
(式中、Xは窒素原子またはC−R6を表す。R1は任意の置換基を表す。R 2 、R 4、R5、R 6 は水素原子を表す。R 3 は置換基を有していてもよいアルキル基、シクロアルキル基、アルケニル基、シクロアルケニル基、アルコキシ基、アルキルチオ基、アラルキル基、アルケニルオキシ基、アリール基、飽和もしくは不飽和の複素環基、ハロゲン原子、ニトロ基、シアノ基、ホルミル基、ヒドロキシ基、カルボキシル基、スルホン酸基、アミノ基、アシルアミノ基、カーバメート基、スルホンアミド基、カルバモイル基、カルボン酸エステル基、スルファモイル基及びスルホン酸エステル基から選ばれる基である。R 7 およびR 8 は、各々独立に置換基を有してもよいアルキル基、アルケニル基、アラルキル基、又はアシル基であるか、R 7 とR 8 が結合せず、R 7 とR 6 、及びR 8 とR 5 の1以上が結合して環を形成していてもよい。)
An optical recording medium in which a recording layer capable of recording and / or reproducing information by a laser is provided on a substrate, and the carbostyryl compound represented by the following general formula [I] or 1,8 An optical recording medium containing a naphthyridine compound.
Figure 2003127542
(In the formula, X represents a nitrogen atom or C—R 6. R 1 represents an arbitrary substituent. R 2 , R 4 , R 5 and R 6 represent a hydrogen atom. R 3 has a substituent. Alkyl group, cycloalkyl group, alkenyl group, cycloalkenyl group, alkoxy group, alkylthio group, aralkyl group, alkenyloxy group, aryl group, saturated or unsaturated heterocyclic group, halogen atom, nitro group, It is a group selected from cyano group, formyl group, hydroxy group, carboxyl group, sulfonic acid group, amino group, acylamino group, carbamate group, sulfonamide group, carbamoyl group, carboxylic acid ester group, sulfamoyl group and sulfonic acid ester group. R 7 and R 8 are each independently an optionally substituted alkyl group, alkenyl group, aralkyl group, or acyl group, or R 7 7 and R 8 may not be bonded , and one or more of R 7 and R 6 and R 8 and R 5 may be bonded to form a ring.)
一般式[I]においてR1が置換基を有していてもよいアルキル基、シクロアルキル基、アルケニル基、シクロアルケニル基、アラルキル基、アリール基、飽和もしくは不飽和の複素環基、アシル基から選ばれる基を表すことを特徴とする請求項1に記載の光学記録媒体。In the general formula [I], R 1 may be substituted from an alkyl group, a cycloalkyl group, an alkenyl group, a cycloalkenyl group, an aralkyl group, an aryl group, a saturated or unsaturated heterocyclic group, and an acyl group. The optical recording medium according to claim 1, wherein the optical recording medium represents a selected group. 情報の記録及び/又は再生用レーザー光波長が350nm〜530nmであることを特徴とする請求項1または2に記載の光学記録媒体。The optical recording medium according to claim 1 or 2 , wherein a laser beam wavelength for recording and / or reproducing information is 350 nm to 530 nm.
JP2001322562A 2001-10-19 2001-10-19 Optical recording medium Expired - Fee Related JP4178783B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001322562A JP4178783B2 (en) 2001-10-19 2001-10-19 Optical recording medium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001322562A JP4178783B2 (en) 2001-10-19 2001-10-19 Optical recording medium

Publications (3)

Publication Number Publication Date
JP2003127542A JP2003127542A (en) 2003-05-08
JP2003127542A5 true JP2003127542A5 (en) 2005-06-16
JP4178783B2 JP4178783B2 (en) 2008-11-12

Family

ID=19139592

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001322562A Expired - Fee Related JP4178783B2 (en) 2001-10-19 2001-10-19 Optical recording medium

Country Status (1)

Country Link
JP (1) JP4178783B2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235551B2 (en) 2000-03-02 2007-06-26 Smithkline Beecham Corporation 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
CZ20031125A3 (en) 2000-10-23 2003-10-15 Smithkline Beecham Corporation Novel compounds
JP2006517976A (en) 2003-02-14 2006-08-03 スミスクライン・ビーチャム・コーポレイション New compounds
EP1719635A1 (en) * 2004-02-26 2006-11-08 Mitsubishi Chemical Corporation Optical recording material and optical recording medium
TWI389690B (en) 2005-03-25 2013-03-21 Glaxo Group Ltd Novel compounds
EP1868612A4 (en) 2005-03-25 2010-03-24 Glaxo Group Ltd Novel compounds
WO2006104917A2 (en) 2005-03-25 2006-10-05 Glaxo Group Limited Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1h)-one derivatives
PE20100741A1 (en) 2005-03-25 2010-11-25 Glaxo Group Ltd COMPOUNDS DERIVED FROM 3,4-DIHYDROPYRIMIDE [4,5-d] PYRIMIDIN-2 (1H) -ONE AS KINASE INHIBITORS p38
AU2008317400B2 (en) 2007-10-22 2014-10-02 Sunesis Pharmaceuticals, Inc. Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino) -1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3- carboxylic acid in combination therapy
SG172457A1 (en) 2008-12-31 2011-08-29 Sunesis Pharmaceuticals Inc Method of preparing (+)-1,4-dihydro-7-[(3s,4s)-3methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
UA110465C2 (en) 2009-09-04 2016-01-12 Sunesis Pharmaceutecals Inc Stable sns-595 composition
TW201120037A (en) 2009-10-26 2011-06-16 Sunesis Pharmaceuticals Inc Compounds and methods for treatment of cancer

Similar Documents

Publication Publication Date Title
JP2003127542A5 (en)
GB2373364A (en) Fly height control over patterned media
JP2005509694A5 (en)
JP2002539323A5 (en)
JP2004525800A5 (en)
EP1602968A3 (en) Optical multilayer disk, multiwavelength light source, and optical system using them
TW200712132A (en) Optical recording medium, optical recording material and metal complex compound
EP1134611A3 (en) Photothermographic material and method for forming images
JP2006512335A5 (en)
JP2001287466A5 (en)
JP2004525798A5 (en)
JP2005500923A5 (en)
EP1229528A3 (en) Information recording medium
JP2010006793A5 (en) Optical recording composition, holographic recording medium, and information recording / reproducing method
WO2003063151A3 (en) Optical recording materials having high storage density
TW430616B (en) Optical information recording medium
KR970002913A (en) Optical recording media
JP2005520835A5 (en)
JP2005515914A5 (en)
EP1339047A3 (en) Apparatus and method for recording and/or reproducing optical information
WO2005000972A3 (en) Optical recording materials having high storage density
ATE396865T1 (en) IMAGE RECORDING MATERIAL
JP2005119165A5 (en)
WO2005081240A3 (en) Optical recording materials writable using blue lasers
JP2000280620A5 (en) Optical recording medium and its compound for recording layer